Skip to main content
    P

    Prime Medicine, Inc. Common Stock (PRME)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.19
    -0.08 (-1.87%)

    Market Cap: $949.85M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Prime Medicine, Inc. Common Stock (PRME) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Prime Medicine, Inc. Common Stock (PRME) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, Prime Medicine, Inc. Common Stock reported EPS of -$0.22, above the -$0.23 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    29%(5/17)
    Avg Surprise
    -18.36%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 1, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.23
    Range-$0.31 - -$0.04
    17 analysts
    Revenue Consensus
    $2.40M
    RangeN/A
    14 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.26
    Range-$0.35 - -$0.19
    6 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.30+12.8%
    60d ago-$0.26-1.4%
    30d ago-$0.26-1.4%
    7d ago-$0.26-1.4%
    Current-$0.26
    Revenue Consensus
    $1.09M
    RangeN/A
    5 analysts

    Next Report

    PRME has an expected report date of Mar 1, 2027.

    Earnings History

    Of the 17 quarters below that had an estimate, PRME beat 5, missed 11 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $4.21M, up 242.3% from $1.23M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.22-$0.23-$0.30 - -$0.19+4.35%BeatN/A141 up, 1 downNov 12, 2026$4.21M
    Jun 30, 2026-$0.24-$0.24-$0.29 - -$0.180.00%In lineN/A131 up, 1 downAug 6, 2026$1.15M
    Mar 31, 2026-$0.28-$0.25-$0.28 - -$0.19-12.00%MissN/A112 up, 2 downMay 7, 2026$856000
    Dec 31, 2025-$0.24-$0.26-$0.31 - -$0.19+6.90%BeatN/A112 up, 5 downMar 3, 2026$838000
    Sep 30, 2025-$0.32-$0.25-$0.33 - -$0.21-28.00%MissN/A108 up, 0 downNov 7, 2025$1.23M
    Jun 30, 2025-$0.41-$0.36-$0.42 - -$0.26-13.89%MissN/A101 up, 0 downAug 7, 2025$1.11M
    Mar 31, 2025-$0.40-$0.31-$0.35 - -$0.18-29.03%MissN/A82 up, 1 downMay 8, 2025$1.45M
    Dec 31, 2024-$0.31-$0.49N/A+36.73%BeatN/A107 up, 1 downFeb 28, 2025$2.18M
    Sep 30, 2024-$0.44-$0.42-$0.48 - -$0.35-4.76%MissN/A111 up, 0 downNov 12, 2024$209000
    Jun 30, 2024-$0.46-$0.39-$0.43 - -$0.37-17.95%MissN/A120 up, 0 downAug 8, 2024N/A
    Mar 31, 2024-$0.44-$0.46-$0.57 - -$0.41+4.35%BeatN/A90 up, 0 downMay 10, 2024$591000
    Dec 31, 2023-$0.72-$0.51-$0.58 - -$0.44-41.18%MissN/A80 up, 0 downMar 1, 2024$25.69M
    Sep 30, 2023-$0.55-$0.46-$0.54 - -$0.39-19.57%MissN/A70 up, 0 downNov 3, 2023N/A
    Jun 30, 2023-$0.47-$0.42-$0.47 - -$0.39-11.90%MissN/A60 up, 0 downAug 7, 2023N/A
    Mar 31, 2023-$0.44-$0.41-$0.50 - -$0.37-7.32%MissN/A41 up, 0 downMay 11, 2023N/A
    Dec 31, 2022-$0.56-$0.65-$1.59 - -$0.31+13.85%BeatN/A40 up, 0 downMar 9, 2023$5.21M
    Sep 30, 2022-$1.61-$0.55N/A-192.73%MissN/AN/AN/AOct 21, 2022N/A
    Mar 31, 2022-$0.32N/AN/AN/AN/AN/AN/AN/AJun 29, 2022N/A
    Sep 30, 2021-$0.24N/AN/AN/AN/AN/AN/AN/ADec 20, 2021N/A
    Last 19 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.37, after -$1.65 the year before. It was -$2.73 for the year ended Dec 31, 2022, the oldest of the 4 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.37N/A
    Dec 31, 2024-$1.65N/A
    Dec 31, 2023-$2.18N/A
    Dec 31, 2022-$2.73N/A

    Frequently Asked Questions About PRME

    When is Prime Medicine, Inc. Common Stock's next earnings date?

    Prime Medicine, Inc. Common Stock's next earnings report is expected for Mar 1, 2027.

    Did PRME beat earnings estimates last quarter?

    Yes. Prime Medicine, Inc. Common Stock reported EPS of -$0.22 for the quarter ended Sep 30, 2026, above the -$0.23 estimate, a 4.35% surprise.

    What EPS do analysts expect from PRME next quarter?

    The consensus EPS estimate for Prime Medicine, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.23 from 17 analysts, with estimates from -$0.31 to -$0.04.

    How often does PRME beat earnings estimates?

    Prime Medicine, Inc. Common Stock beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -4.37%.